Jan Grimm

4.2k citations

19 papers · 783 indexed · h-index 12

Impact in

Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
Biological Psychiatry

Papers in

Neurology 3
- Neuroinflammation and Neurodegeneration Mechanisms 3
Physiology 7
- Alzheimer's disease research and treatments 7

Co-authors: Roger M. Nitsch Stanley Falkow Anne Mueller Dave Morgan Arnon Rosenthal Victoria Ronan Paul E. Gottschall Marcia N. Gordon
Journals: Nature Communications (2 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (2 papers)Journal of Vascular and Interventional Radiology (2 papers)Cell Death and Disease (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
Partner nations: Germany United States Switzerland

In The Last Decade

Jan Grimm

18 papers receiving 757 citations

Peers

Countries citing papers authored by Jan Grimm

Since Specialization

Citations

This map shows the geographic impact of Jan Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Grimm more than expected).

Fields of papers citing papers by Jan Grimm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Grimm. The network helps show where Jan Grimm may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Grimm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Grimm Line = papers co-authored together Jan Grimm links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Prediction of Cardiac ATTR Depletion by NI006 (ALXN2220) Using Mechanistic PK/PD Modeling Clinical Pharmacology & Therapeutics ·Aubin Michalon, Serhan GÜVEN, Matthias Macháček, Phil Bronstein, Chandrasekhar Udata, Toro Barragán, Д.И. Багалей, Christoph Höck, Roger M. Nitsch, Peter C. Kahr, Jan Grimm	2024	1
2	Long-term safety and efficacy of antibody ALXN2220 for depletion of cardiac amyloid transthyretin: results of treatment beyond 12 months in the open-label extension of study NI006-101 European Heart Journal ·Peter van der Meer, Olivier Lairez, Erwan Donal, Fabian aus dem Siepen, Arnt V. Kristen, Thibaud Damy, Cristina Quarta, Michele Mercuri, Roger M. Nitsch, Jan Grimm, Sergio Rey, M. Tichý, Peter C. Kahr, Carly Laxon-Takooree, Pablo García‐Pavía	2024	0
3	A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models Nature Communications ·Scott McKenzie, Fabrice D. Heitz, Puteri Sofia Amirnuddin, Neil U. Maitra, Karin Breu, Heather C. Denroche, Julien Thévenet, Melania Osto, Paolo Arosio, Julie Kerr‐Conte, C. Bruce Verchere, François Pattou, Thomas A. Lutz, Marc Y. Donath, Christoph Höck, Roger M. Nitsch, Jan Grimm	2023	13
4	A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells Nature Communications ·Aubin Michalon, Michael Vinicius Sordi, Sandra Z. Salan, Muhammad Iqbal Ardiansyah Ukkas, Benoît Combaluzier, Thibaud Damy, Ole B. Suhr, Maria João Saraiva, Christoph Höck, Roger M. Nitsch, Jan Grimm	2021	74
5	Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models Neurobiology of Disease ·Andreas Weihofen, Yuting Liu, Joseph W. Arndt, N.A. Mironov, Chao Quan, Benjamin Smith, A.M. SHAHABUDDIN, 박서정, Guangwei Zhu, Lihe Su, Galina Marsh, Pavan K. Auluck, Fabio Montrasio, Roger M. Nitsch, Warren D. Hirst, Yao Ya-xi, R. Blake Pepinsky, Jan Grimm, C. Wadelius	2018	136
6	NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss Cell Death and Disease ·Christian Tackenberg, Timothy C. Steele, N. Ty Smith, Antonella Santuccione Chadha, Stefan Milton, Uwe Konietzko, Jan Grimm, Roland Brandt, Roger M. Nitsch	2013	111
7	Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice Molecular Psychiatry ·Antonella Santuccione Chadha, Mario Merlini, 彭元芝, Christian Tackenberg, Jitin Bali, Maria Teresa Ferretti, Jordan McAfoose, Luka Kulic, Christian Bernreuther, Tobias Welt, Jan Grimm, Markus Glatzel, Lawrence Rajendran, C. Hock, Roger M. Nitsch	2012	23
8	Deglycosylated Anti-Aβ Antibody Dose–Response Effects on Pathology and Memory in APP Transgenic Mice Journal of Neuroimmune Pharmacology ·Rachel Karlnoski, Arnon Rosenthal, Jennifer Alamed, Victoria Ronan, Marcia N. Gordon, Paul E. Gottschall, Jan Grimm, Jaume Pons, Dave Morgan	2008	18
9	Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice Journal of Neuroinflammation ·Nikisha Carty, Donna M. Wilcock, Arnon Rosenthal, Jan Grimm, Jaume Pons, Victoria Ronan, Paul E. Gottschall, Marcia N. Gordon, Dave Morgan	2006	38
10	Deglycosylated Anti-Amyloid-β Antibodies Eliminate Cognitive Deficits and Reduce Parenchymal Amyloid with Minimal Vascular Consequences in Aged Amyloid Precursor Protein Transgenic Mice Journal of Neuroscience ·Donna M. Wilcock, Jennifer Alamed, Paul E. Gottschall, Jan Grimm, Arnon Rosenthal, Jaume Pons, Victoria Ronan, Khanh-Ngoc Hoang-Tran, Marcia N. Gordon, Dave Morgan	2006	126
11	Profiling of microdissected gastric epithelial cells reveals a cell type—specific response to Helicobacter pylori infection Gastroenterology ·Anne Mueller, D. Scott Merrell, Jan Grimm, Stanley Falkow	2004	47
12	Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter- induced mucosa-associated lymphoid tissue lymphoma Proceedings of the National Academy of Sciences ·Anne Mueller, Jani O’Rourke, Jan Grimm, Karen Guillemin, Michael F. Dixon, Adrian V. Lee, Stanley Falkow	2003	93
13	Endovascular Placement of Self-expanding Nitinol Coil Stents for the Treatment of Femoropopliteal Obstructive Disease Journal of Vascular and Interventional Radiology ·Thomas Jahnke, Götz Voshage, Stefan Müller‐Hülsbeck, Jan Grimm, Martin Heller, J. Brossmann	2002	65
14	Evaluation of hydroxyapatite implants in vertebral bodies and extremities by contrast-enhanced magnetic resonance imaging Archives of Orthopaedic and Trauma Surgery ·Jan Grimm, Stefan Mueller‐Huelsbeck, Paula Riikonen, H.-J. Egbers, G. Brinkmann, Martin Heller	2001	2
15	Treatment of Infrapopliteal Occlusive Disease by High-speed Rotational Atherectomy: Initial and Mid-term Results Journal of Vascular and Interventional Radiology ·Thomas Jahnke, Huijeong 이희정Lee, Chuong Hoang Le Duy, Jan Grimm, Martin Heller, Pawel Franciszek Anaszkiewicz Graczykowska	2001	17
16	Flow patterns from metallic vascular endoprostheses: in vitro results European Radiology ·Stefan Müller‐Hülsbeck, Jan Grimm, Thomas Jahnke, Jooran Lee, Martin Heller	2001	7
17	Erste Ergebnisse nach Implantation des neuen ballonexpandierbaren BridgeTM-Stents in die Beckenarterien RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Stefan Müller‐Hülsbeck, Jan Grimm, Thomas Jahnke, J. Brossmann, D. E. MacKay, Martin Heller	2000	2
18	Mittelfristige Ergebnisse nach Implantation des neuen ballon-expandierbaren VIP®-Stents in die Beckenarterien RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Thomas Jahnke, J. Brossmann, Götz Voshage, D. E. MacKay, Stefan Müller‐Hülsbeck, Jan Grimm, Zanyar Othman Omer, Martin Heller	2000	2
19	Antimycotic Therapy with Liposomal Amphotericin-B for Patients Undergoing Bone Marrow or Peripheral Blood Stem Cell Transplantation Leukemia & lymphoma ·Kateřina Sedláková, M Stockschläder, Ingo Sobottka, Michael A. Via, Maike de Wit, Nicolaus Kröger, Jan Grimm, N M Chikhladze, Walter Fiedler, R. Erttmann, Axel R. Zander	1997	8

About Jan Grimm

Jan Grimm is a scholar working on Neurology, Physiology, Surgery, Rheumatology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 783 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Peripheral Artery Disease Management (4 papers), Glycosylation and Glycoproteins Research (3 papers), Vascular Procedures and Complications (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Coronary Interventions and Diagnostics (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Neurology (141 citations), Biological Psychiatry (30 citations), Physiology (306 citations), Cellular and Molecular Neuroscience (167 citations) and Neurology (122 citations). Jan Grimm has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Roger M. Nitsch, Stanley Falkow, Anne Mueller, Dave Morgan, Arnon Rosenthal, Victoria Ronan, Paul E. Gottschall, Marcia N. Gordon, Jaume Pons and Donna M. Wilcock. Their work appears in journals such as Nature Communications, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Journal of Vascular and Interventional Radiology, Cell Death and Disease and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact